Fri Sep 20 06:12:51 UTC 2024: ## New COVID Variant XEC on the Rise, Could Become Dominant Globally

**Glasgow, Scotland** – A new COVID-19 variant, XEC, is spreading rapidly and is expected to become the dominant variant globally in the coming months. First detected in Germany in August, XEC is a recombinant variant, formed through the combination of genetic material from two existing variants, KS.1.1 and KP.3.3.

While not a radically different variant, XEC appears to have a growth advantage over other circulating variants. It is currently most prevalent in Germany, followed by the UK and the US. While the exact reasons for its rapid spread are still under investigation, scientists believe a specific combination of mutations in the spike protein could contribute to its transmissibility.

**Similar Symptoms, Potential for Increased Hospitalizations**

Despite its rapid spread, XEC is not anticipated to cause significantly different symptoms than other COVID variants, with common symptoms like fever, sore throat, cough, headaches, and body aches still expected.

However, experts warn that winter months often see an increase in hospitalizations due to colder temperatures and increased indoor gatherings. While this seasonal increase should not be directly attributed to XEC, it is a factor to consider.

**Autumn Booster Campaign Provides Protection**

The UK is set to launch its autumn booster campaign in October, with the updated vaccine targeting the JN.1 variant, from which XEC is derived. This will offer good protection against severe illness from XEC and related variants.

**Continued Monitoring and Evolution of the Virus**

XEC is the latest in a series of COVID-19 variants that are being monitored as the virus continues to evolve. Other closely related variants like MV.1 are also being watched closely, emphasizing the ongoing importance of vigilance and research in understanding the virus’s evolution.

While XEC’s dominance appears likely, it’s important to remember that the virus is constantly evolving, and new variants may emerge and challenge its dominance. This highlights the need for ongoing surveillance and adaptation in our response to the pandemic.

Read More